Department of Environmental and Occupational Health, Drexel University Dornsife School of Public Health, Philadelphia, PA, United States of America.
Department of Community Health and Prevention, Drexel University Dornsife School of Public Health, Philadelphia, PA, United States of America.
PLoS One. 2019 Oct 7;14(10):e0223486. doi: 10.1371/journal.pone.0223486. eCollection 2019.
Adoption of pre-exposure prophylaxis (PrEP) to prevent HIV infection has been slow. The purpose of this study was to evaluate knowledge, attitudes and referral practices for PrEP among non-prescribing providers, who may play key role.
We performed a cross-sectional survey on PrEP knowledge, attitudes, and referral practices among 66 non-prescribing HIV prevention providers (1st August to 31st December, 2016), in Philadelphia, followed by qualitative interviews with 12 of them (5th April to 10th May, 2017).
Participants had a mean age of 36 years, with 62% females. Majority were HIV case managers and rapid testers. For half of the respondents, PrEP eligibility screening was part of rapid HIV testing at their organization, 40% never had PrEP training and only 27% indicated personally screening clients for eligibility. Qualitative data revealed that participants held positive attitudes about PrEP and perceived organizational support, but had concerns about potential negative impacts and barriers to routine HIV screening.
Results highlight the importance of training non-prescribing HIV prevention providers about PrEP, addressing their concerns, and incorporating PrEP screening and referral into routine HIV testing.
预防艾滋病毒感染的暴露前预防(PrEP)的采用一直很慢。本研究的目的是评估非处方提供者(他们可能发挥关键作用)对 PrEP 的知识、态度和转介做法。
我们在费城对 66 名非处方 HIV 预防提供者(2016 年 8 月 1 日至 12 月 31 日)进行了 PrEP 知识、态度和转介做法的横断面调查,随后对其中的 12 人进行了定性访谈(2017 年 4 月 5 日至 5 月 10 日)。
参与者的平均年龄为 36 岁,其中 62%为女性。大多数是 HIV 病例管理者和快速检测员。对于一半的受访者来说,PrEP 资格筛选是其所在组织快速 HIV 检测的一部分,40%的人从未接受过 PrEP 培训,只有 27%的人表示个人为客户进行资格筛选。定性数据显示,参与者对 PrEP 持积极态度,并认为得到了组织的支持,但对潜在的负面影响和常规 HIV 筛查的障碍表示担忧。
结果强调了对非处方 HIV 预防提供者进行 PrEP 培训、解决他们的担忧以及将 PrEP 筛查和转介纳入常规 HIV 检测的重要性。